Cell Bio-Systems Pursuing Government Grants for Stem Cell Research; Retains Leading Biotech Consultant to Manage Submissions Process.SAN DIEGO San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. -- Cell Bio-Systems Inc. (Pink Sheets: CBSI CBSI CUNA Brokerage Services, Inc. CBSI Cambodian Buddhist Society, Inc. (Silver Springs, Maryland) CBSI Certified Bridge Safety Inspector CBSI Custom Business Solutions, Inc. ), a biotechnology company positioned to manufacture and distribute patented, disposable technologies for stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. research, cosmetic surgery cosmetic surgery, plastic surgery for cosmetic purposes, such as the improvement of the appearance of the face by removing wrinkles or reshaping the nose. and other living tissue procedures, announced today that it is pursuing several research grants offered by state and federal government agencies for the development of medical devices used in stem cell research. Stem cell research is a political hot topic. From Nancy Reagan to John Kerry "Cell Bio-Systems is positioning itself to be a major factor in this market, with government funding facilitating advancements in available instrumentation," said Marc Pilkington, Cell Bio-Systems President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . To further this leadership initiative, Cell Bio-Systems has retained Brian Pockett, a well-respected industry consultant, to assist with the company's grant submissions. Pockett brings an extensive background in successfully obtaining government grants for product development. His particular expertise is in obtaining funding for research and development of medical devices for the biotechnology industry. With more than 28 years of professional experience in business development and grant submissions, Pockett is expected to be a key addition in the company's development efforts for instrumentation utilized in stem cell harvesting and research. "Cell Bio-Systems will be using its patented and proprietary technology to develop instrumentation used in stem cell research, as well as genome therapies; we believe our technologies will result in major advancements in these areas," added Pilkington. "With renewed interest in stem cell research by the federal government, numerous state governments, and related private foundations, our company plans on garnering funds to develop and expand the types of precision instrumentation necessary to support stem cell research and genome therapies." About Cell Bio-Systems Based in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation). San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. , Cell Bio-Systems is the exclusive licensee of two patented syringe connection products that it plans to adapt as disposable devices for liposuction Liposuction Definition Liposuction, also known as lipoplasty or suction-assisted lipectomy, is cosmetic surgery performed to remove unwanted deposits of fat from under the skin. and other Living Tissue Management(TM) procedures. The company is developing an affordable, disposable product Disposable products are items that are not intended by the manufacturer to be reused more than once or a few times as compared to more permanent serviceable and reusable items. Some products that have disposable versions are:
The process by which the corporation communicates with its investors. " page to receive ongoing CBSI news updates. Legal Notice Regarding Forward-Looking Statements: "Forward-looking statements" as defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 may be included in this news release. These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. CBSI disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to risks associated with changes in general economic and business conditions (including in the information technology and financial information industry), actions of our competitors, the extent to which we are able to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our services, and changes in our business strategies. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion